GeneDx (WGS) - Net Sales Margin

Brandmark of Sema4 (WGS)

Demand for the early detection of rare pathologies is driving industry growth. GeneDx Holdings Corp. (WGS) generates revenue through high-precision whole-exome sequencing and molecular diagnostics. Meanwhile, business profitability relies on AI implementation and the scaling of test volumes. Net margin dynamics demonstrate effective cost control, and the -24.10 metric reflects the company's current sales profitability trend.

genedx.com (WGS) Company Sales Margin: for the period 04/28/2023 - 11/20/2026

Analytical breakdowns and data insights for company GeneDx Corp (WGS)

- market value and analyst target forecast:
Comprehensive company analysis:GeneDx Holdings Corp.
Flagship merchandise of Sema4

GeneDx Holdings Corp. (WGS) leadership in genomic sequencing and its unique exome database should translate into high efficiency, as reflected by the net profit margin. This indicator measures the portion of profit in every dollar of revenue, demonstrating the business's ability to maintain profitability under pessimistic scenarios. A decline in this metric signals a loss of financial strength, making the purchase of shares risky.

Who GeneDx Holdings Corp. competes with

TEM: Net Sales Margin|Net Profitability Margin Qiagen QGEN|IONS (Isis Pharmaceuticals) - Net Sales Margin|Repligen Inc. - Net Profit Margin|Net Sales Margin RNA|CRSP - Net Margin|Net Margin Ultragenyx RARE|Company Sales Margin Beam Therapeutics (BEAM)|SRPT: Return on Sales by Net Profit|Net Margin Twist Bioscience|TXG (10x Genomics) - Return on Sales by Net Profit|Intellia Therapeutics, Inc. (NTLA) - Net Sales Margin|Net Margin Stoke Therapeutics Inc|BLFS: Net Profit Rate|Return on Sales by Net Profit WVE (Wave Life Sciences Corp)|Company Sales Margin Maze Therapeutics Corp|Sionna Therapeutics Inc - Return on Sales by Net Profit|PRME (primemedicine.com) - Net Profit Margin|TSHA - Net Margin|QURE (uniQure) - Net Return on Sales|MeiraGTx Corp (MGTX) - Net Margin|Regenxbio - Net Profit Rate|Net Margin solidbio.com|Net Margin ocugen.com OCGN|Net Sales Margin PACB|Benitec - Net Return on Sales|Net Margin Design Therapeutics DSGN|Net Sales Margin Rocket Pharmaceuticals RCKT|Net Profit Margin 4D Molecular Corp|LXEO: Net Margin|KRRO (Korro Bio, Inc) - Return on Sales by Net Profit|Editas Medicine (EDIT) - Net Sales Margin|Net Margin Silence Therapeutics Inc.|Net Return on Sales PRQR (proqr.com)|Net Margin Codexis Bio (CDXS)|Net Sales Margin sangamo.com (SGMO)|Net Margin nautilus.bio NAUT|Company Sales Margin Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Net Sales Margin|GBIO - Net Sales Margin|BOLD: Net Sales Margin|Net Return on Sales XCUR|Net Margin Imunon|Phio Pharmaceuticals - Net Profit Margin|Net Margin Mustang Bio, Inc. (MBIO)|Company Sales Margin TransCode Therapeutics, Inc.|Net Margin Bionano Genomics BNGO|Net Profit Rate APDN|BLUE - Net Margin|Net Profit Margin IPA|Omega Therapeutics, Inc. (OMGA) - Net Margin|Singular Genomics Corp (OMIC) - Net Sales Margin|RGLS (Regulus Therapeutics, Inc.) - Net Sales Margin|SYRS: Net Profit Rate|Return on Sales by Net Profit TBIO (Telesis Bio Inc.)|Net Sales Margin TRACON Pharmaceuticals Inc. (TCON)|Net Margin Unity Bio UBX